Xiaobing Niu

1.3k total citations
37 papers, 979 citations indexed

About

Xiaobing Niu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaobing Niu has authored 37 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Xiaobing Niu's work include Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (11 papers) and MicroRNA in disease regulation (10 papers). Xiaobing Niu is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (11 papers) and MicroRNA in disease regulation (10 papers). Xiaobing Niu collaborates with scholars based in China, United States and South Korea. Xiaobing Niu's co-authors include Zengjun Wang, Bin Xu, Pengchao Li, Xinru Wang, Jun Tao, Deyao Wu, Lixin Hua, Ninghan Feng, Wei Zhang and Na Tong and has published in prestigious journals such as PLoS ONE, Scientific Reports and Gene.

In The Last Decade

Xiaobing Niu

35 papers receiving 963 citations

Peers

Countries citing papers authored by Xiaobing Niu

Since Specialization

Citations

This map shows the geographic impact of Xiaobing Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Niu more than expected).

Fields of papers citing papers by Xiaobing Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Niu. The network helps show where Xiaobing Niu may publish in the future.

Co-authorship network of co-authors of Xiaobing Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Niu. A scholar is included among the top collaborators of Xiaobing Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Niu. Xiaobing Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer 2025 ·Scientific Reports ·Jiawei Zhang, Feng Ding, (unknown), Xiaoying Wei, (unknown), Feng Xu, Huixing Chen, Zhongying Guo, Zonghao You, Boyun Liang, I‐Ming Chen, (unknown), Xiaobing Niu, Xiangxue Wang, (unknown)	0
2	Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), (unknown), Yuze Ma, Xiaobing Niu, Suan Sun, Guihua Hou, (unknown), Feng Gao	6
3	Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classification 2022 ·Japanese Journal of Clinical Oncology ·(unknown), Xiaobing Niu, Bing Zhong	5
4	Investigation of Leptin G19A polymorphism with bladder cancer risk: A case‐control study 2020 ·Journal of Clinical Laboratory Analysis ·Fei Mao, Xiaobing Niu, Shuo Gu, Lü Ji, (unknown), Hengbing Wang	5
5	lncRNA MORT Regulates Bladder Cancer Behaviors by Downregulating MicroRNA-146a-5p 2020 ·The Nephron journals/Nephron journals ·Yunyan Wang, Qing Sun, Lü Ji, Gongcheng Wang, Xiaobing Niu, Suan Sun	9
6	<p>Hsa_circRNA_100146 Acts as a Sponge of miR-149-5p in Promoting Bladder Cancer Progression via Regulating <em>RNF2</em></p> 2020 ·OncoTargets and Therapy ·Hengbing Wang, Xiaobing Niu, Fei Mao, (unknown), Bing Zhong, Hesong Jiang, Guangbo Fu	13
7	MR urethrography versus X-ray urethrography compared with operative findings for the evaluation of urethral strictures 2019 ·International Urology and Nephrology ·(unknown), (unknown), Guangbo Fu, Xiaobing Niu, (unknown), Gongcheng Wang	5
8	<p>ZNF433 positively regulates the beta-catenin/TCF pathway in prostate cancer and enhances the tumorigenicity of cancer cells</p> 2019 ·OncoTargets and Therapy ·Shuo Gu, (unknown), (unknown), Xiaobing Niu, (unknown), Fei Mao, (unknown)	1
9	The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population 2019 ·Clinical and Experimental Medicine ·Fei Mao, Xiaobing Niu, Shuo Gu, Lü Ji, (unknown), (unknown)	9
10	NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells 2018 ·Chemico-Biological Interactions ·Shuo Gu, (unknown), (unknown), Xiaobing Niu, (unknown), Fei Mao, (unknown)	4
11	MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2 2017 ·Oncology Reports ·Deyao Wu, Xiaobing Niu, Jun Tao, Pengchao Li, Qiang Lü, Aiming Xu, Wei Chen, Zengjun Wang	45
12	miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling 2016 ·Oncology Letters ·(unknown), Qi Li, Xiaobing Niu, Gongcheng Wang, (unknown), Guangbo Fu, Zengjun Wang	53
13	Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1 2016 ·Oncology Letters ·Deyao Wu, Xiaobing Niu, HUIXING PAN, Yunfeng Zhou, (unknown), Ping Qü, Jian Zhou	19
14	MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility 2016 ·Molecular Medicine Reports ·Deyao Wu, Xiaobing Niu, HUIXING PAN, (unknown), Yunfeng Zhou, Ping Qü, Jian Zhou	13
15	Variants in the SRD5A2 gene are associated with quality of semen 2012 ·Molecular Medicine Reports ·Dan Zhao, Wei Wu, Bin Xu, Xiaobing Niu, (unknown), Yi Zhang, Zengjun Wang, Xinru Wang	17
16	MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer 2011 ·The Prostate ·Bin Xu, Ning Wang, Xuhui Wang, Na Tong, Ning Shao, Jun Tao, Pengchao Li, Xiaobing Niu, Ninghan Feng, Lihua Zhang, Lixin Hua, Zengjun Wang, Ming Chen	143
17	IL-6 −174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls 2010 ·Molecular Biology Reports ·Bin Xu, Xiaobing Niu, (unknown), (unknown), Na Tong, Yuanyuan Mi, (unknown), Jun Tao, Pengchao Li, Wei Zhang, Hongfei Wu, Zhengdong Zhang, Zengjun Wang, Lixin Hua, Ninghan Feng, Xinru Wang	36
18	Idiopathic Male Infertility Is Strongly Associated with Aberrant Promoter Methylation of Methylenetetrahydrofolate Reductase (MTHFR) 2010 ·PLoS ONE ·Wei Wu, Ouxi Shen, Yufeng Qin, Xiaobing Niu, Chuncheng Lu, Yankai Xia, Ling Song, Shoulin Wang, Xinru Wang	113
19	Novel methods for the diagnosis and treatment of ejaculatory duct obstruction 2010 ·British Journal of Urology ·Bin Xu, Xiaobing Niu, Zengjun Wang, Pengchao Li, Chao Qin, Jie Li, Bianjiang Liu, Peng Wang, (unknown), Hongfei Wu, Wei Zhang	25
20	miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS 2010 ·Molecular and Cellular Biochemistry ·Bin Xu, Xiaobing Niu, Xiangxiang Zhang, Jun Tao, Deyao Wu, Zidun Wang, Pengchao Li, Wei Zhang, Hongfei Wu, Ninghan Feng, Zengjun Wang, Lixin Hua, Xinru Wang	166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact